מרכז רפואי כרמל, חיפה

ד"ר דבי זיסמן

מנהלת יחידת ראומטולוגיה

פרטים אישיים

ד"ר דבי זיסמן
  • תפקידים ומינויים

    מנהלת יחידה ראומטולוגית ויו"ר ועדת אקדמיה והוראה.
    ​מרצה קליני בפקולטה לרפואה, טכניון.

  • השכלה

    ​הפקולטה לרפואה של הטכניון (1987), בהצטיינות.

  • התמחות

    ​מומחית ברפואה פנימית (מרכז רפואי כרמל 1996).
    תת התמחות בראומטולוגיה
    BAYLOR COLLEGE OF MEDICINE 1996-1998

  • השתלמויות

    2014 - ​אוניברסיטת סטנפורד ארה"ב
    2009 - מרכז וסקוליטיס קליוולנדקליניקס אוהיו ארה"ב
    Visiting Physician, Center for Vasculitis, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland,

    OH, USA

     

    תחומי מחקר

    - דלקת מפרקים קשורה לפסוריאזיס
    - טיפולים ביולוגים במחלות ראומטיות

  • פרסומים נבחרים

    1.        Danenberg HD, Lerman Y, Steinlauf S, Salomon A, Zisman D, Atsmon J, Slater PE. Mortality in Israel during the Persian Gulf War initial observation. Israel Journal of Medical Sciences 1991; 27(11-12): 627-630.

    2.        Habib GS, Zisman D. Unusual cluster of parvovirus arthritis. Isr Med Assoc J. 2002; 4(4);314.

    3.        Eder L, Rozenbaum M. Boulman M, Aayubknanov E, Wolfovitz E, Zisman D. Rosner I. Behcet's disease, myelodysplastic syndrome, trisomy 8, gastroenterological involvement – an association. Clin Exp Rehumatol. 2005; 23:S91-95.

    4.        Eder L, Zisman D, Rozenbaum M, Rosner I. Clinical features and etiology of septic arthritis in northern Israel. Rheumatol 2005; 44(12):1559-1563.

    5.        Rimer D, Rozenbaum M, Zisman D, Boulman N, Eder L, Feld J, Rosner I. Giant cell arteritis – the methotrexate debate revisited. J Rheumatol. 2006; 33(7):1458-1459.

    6.        Kessel A, Toubi E, Rozenbaum M, Zisman D, Sabo E, Rosner I. Sjogren's syndrome in the community: can serology replace salivary gland biopsy? Rheumat Int 2006; 26(4):337-339.

    7.        Krause I, Yankevich A, Fraser A, Rosner I, Mader R, Zisman D, Boulman N, Rozenbaum M, Weinberger A. Prevalence and clinical aspects of Behcet's disease in the north of Israel. Clin Rheumatol. 2007; 26(4):555-560.

    8.        Rozenbaum M. Boulman N, Slobodin G, Zisman D, Mader R, Yankevitch A, Weinberger A, Rosner I. Behcet disease in adult Druzes in north Israel: the influence of ethnic origin on disease expression and severity. J Clin Rheumatol. 2007; 13 (3):124-127.

    9.        Eder L, Zisman D*, Barzilai M, Laor A, Rahat M, Rozenbaum M, Bitterman H, Feld J, Rimar D, Rosner I. Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol. 2008; 35(5):877-882.

    10.    Feld J, Weiss G, Rosner I, Rozenbaum M, Laor A, Rimar D, Eder L, Bitterman H, Zisman D. Electrocardiographic findings in psoriatic arthritis: a case-controlled study. J Rheumatol. 2008 Dec; 35(12):2379-2382.

    11.    Rimar D, Zisman D, Schendler Y, Benharroch D , Kharenko O , Brodsky A, Okopnik M, Bitterman H. Kikuchi Fujimoto disease in Israel—more than a pain in the neck. Semin Arthritis Rheum. 2010; 39(6):515-520.

    12.    Zisman D, Eder L, Elias M, Laor A, Bitterman H, Rozenbaum M, Feld J, Rimar D, Rosner I. Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel. Rheumatol Int. 2012; 32:595-600.

    13.    Slobodin G, Reyhan I, Avshovich N, Balbir-Gurman A, Boulman N, Elias M, Feld J, Mader R, Markovitz D, Rimar D, Rosner I, Rozenbaum M, Zisman D, Odeh M. Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosis. Clin Rheumatol. 2011; 30(8):1075-1080.

    14.    Touma Z, Eder L, Zisman D, Feld J, Chandran V, Rosen CF, Shen H, Cook RJ, Gladman DD. Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes. Arthritis Care & Research 2011; 63(10):1440-1447.

    15.    Litinsky I, Balbir A, Zisman D, Mandelboim M, Mendelson E, Feld J, Braun Y, Anouk M, Kaufman I, Paran D, Caspi D, Elkayam O. Vaccination against influenza in patients with systemic sclerosis. Clin Exp Rheumatol. 2012 Mar-Apr; 30(2 Suppl 71):S7-11.

    16.    Zisman D, Haddad A, Hashoul S, Laor A, Bitterman H, Rosner I, Eder L, Balbir-Gurman A, Mader R, Milman U. Hospitalizations of patients treated with anti-tumor necrosis factor-α agents – a retrospective cohort analysis. J Rheumatol. 2013 Jan; 40(1):16-22.

    17.    Breuer GS, Ehrenfeld M, Rosner I, Balbir-Gurman A, Zisman D, Oren S, Paran D. Late-onset neutropenia following rituximab treatment for rheumatologic conditions. Clin Rheumatol. 2014 Sep; 33(9):1337-1340.

    18.    Feld J, Kibari A, Rozenbaum M, Riskin-Mashiah S, Eder L, Laor A, Rosner I, Ellias M, Zisman D. The fetal outcomes of pregnancies of systemic lupus erythematosus patients in northern Israel. J Matern Fetal Neonatal Med. 2014 Jul 22: 1-4. J Matern Fetal Neonatal Med. 2015 Mar; 28(5):564-567.

    19.    Zisapel M, Zisman D, Padova H, Kaufman I, Paran D, Feld, Caspi D, Elkayam O. Prevalence of TNFα blocker immunogenicity in psoriatic arthritis. J Rheumatol. 2015 Jan; 42(1):73-8. J Rheumatol. 2015 Jan; 42(1):73-8

    20.    Ogdie A, Schwartzman S, Coates LC, Eder L, Maharaj A, Zisman D, Raychaudhuri S, Reddy SM, Kavanaugh AF, Mease PC, Ritchlin CT, Husni E. Comprehensive Treatment of psoriatic arthritis: managing comorbidities and extra-articular manifestations. J Rheumatol. 2014 Nov; 41(11):2315-22.

    21.    Zisman D, Bitterman H, Shalom G, Feldhamer I, Comanesther D, Batat E, Greenberg-Dotan S, Cohen S, Cohen AD. Psoriatic arthritis treatment and the risk of herpes zoster. Ann Rheum Dis. 2014 Sep 26. pii: annrheumdis-2013-205148. doi: 10.1136/annrheumdis-2013-205148.

    22.       Shalom G, Zisman D*, Bitterman H, Harman-Boehm I, Greenberg-Dotan S, Dreiher J, Feldhamer I, Moser H, Hammerman A, Cohen AD. Systemic therapy for psoriasis and Herpes Zoster: a 500,000 person-year study. JAMA Dermatology 2015 Mar 22:1-7 JAMA Dermatol. 2015 May;151(5):533-538.

    23.       Shalom G, Zisman D, Harman-Boehm I, Biterman H, Greenberg-Dotan S, Polishchuk I, Moser H, Freud T, Feldhamer I, Cohen AD. Factors associated with drug survival of Methotrexate and Acitretin in patients with psoriasis. Acta Derm Venereol. 2015 Nov; 95(8):973-977.

    24.       Furer V, Zisman D, Pokroy-Shapira E, Molad Y, Elkayam O, Paran D. Systemic lupus erythematosus exacerbation following cessation of belimumab treatment. Scand J Rheumatol. 2015 Oct 29; 1-4.

    25.  Zohar A, Cohen AD, Bitterman H, Feldhamer I, Greenberg-Dotan S, Lavi I, Comanesther D, Batat E, Zisman D. Gastrointestinal Comorbidities in Patients with Psoriatic Arthritis. Clin Rheumatol. 2016 Nov;35(11):2679-2684

    26.  Hassan S, Milman U, Feld J, Eder L, Lavi I, Cohen S, Zisman D. Effects of Anti-TNF-α Treatment on Lipid Profile in Rheumatic Diseases – The ASPARA Cohort. Arthritis Res Ther. 2016 Nov 10;18(1):261.

    27.  Zisman D, Gladman DD, Stoll ML, Strand V, Lavi I, Hsu JJ, Mellins ED; and the CARRA Legacy Registry Investigators. The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes. J Rheumatol. 2017 Feb 1. 44(3):342-351

    28.  Haddad A, Zisman D. Comorbidities in Patients with Psoriatic Arthritis. Rambam Maimonides Med J. 2017 Jan 30;8(1).

    29.  Amir Haddad  Ron Ashkenazi, Haim Bitterman,   Ilan Feldhamer, Sari Greenberg-Dotan, Idit Lavi, Erez Batat, Irina Bergman, Arnon Dov Cohen, Devy Zisman Endocrine Comorbidities in Patients with Psoriatic Arthritis: A Population-Based Case Controlled Study J Rheumatology July 2017. 44(6):786-790.